These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Screening for antibodies to HTLV-III/LAV in our population. A word of caution. Zafar MN J Pak Med Assoc; 1987 Apr; 37(4):84-5. PubMed ID: 3108550 [No Abstract] [Full Text] [Related]
3. [Donors with positive antibodies against HIV virus in Red Cross blood banks]. Franco E; Picazo J; Mazón C; Antich JL; Lafulla C; Ribó E; Contreras E Sangre (Barc); 1986; 31(6):775-6. PubMed ID: 3470958 [No Abstract] [Full Text] [Related]
4. Antibodies to human immunodeficiency virus (HTLV-III/LAV) in people from Lagos and Cross River States of Nigeria. Okpara RA; Akinsete I; Williams EE; Schneider J; Wendler I; Hunsmann G Acta Haematol; 1988; 79(2):91-3. PubMed ID: 3124480 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new confirmatory assay for antibodies against lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV III). Abb J Vox Sang; 1986; 51(3):233-5. PubMed ID: 3544497 [TBL] [Abstract][Full Text] [Related]
6. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid]. Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056 [No Abstract] [Full Text] [Related]
7. Screening for anti-HTLV-III/LAV antibody in high-risk subjects: sensitivity and specificity of commercial tests. Lantin JP; Peitrequin R; Frei PC Int Arch Allergy Appl Immunol; 1987; 82(3-4):487-9. PubMed ID: 3553029 [TBL] [Abstract][Full Text] [Related]
9. [Survey of antiviral antibodies against human immunodeficiency virus in a population of 11,174 blood donors]. Muñiz Díaz E; Madoz P; Lluch A Med Clin (Barc); 1987 Nov; 89(16):709-10. PubMed ID: 3480407 [No Abstract] [Full Text] [Related]
10. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations. Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus antibody screening in blood donors from India, Nigeria and Thailand. Kühnl P; Seidl S; Ray V; Kulkarni AG; Mba EC; Chandanayingyong D Vox Sang; 1987; 52(3):203-5. PubMed ID: 3300027 [TBL] [Abstract][Full Text] [Related]
12. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)]. Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290 [No Abstract] [Full Text] [Related]
13. [The prevalence of human immunodeficiency virus (HIV) in blood donors in West Germany and West Berlin]. Glück D; Koerner K; Caspari G; Elbert G; Grässmann W; Hesse R; Holzberger G; Kostuch B; Sternberger J; Vornwald A Beitr Infusionsther; 1988; 21():139-42. PubMed ID: 2462962 [No Abstract] [Full Text] [Related]
14. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing. Ory HW; Koplan JP; Allen JR Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749 [TBL] [Abstract][Full Text] [Related]
15. [Incidence of HTLV-III antibodies in blood donors at the German Red Cross]. Kubanek B; Koerner K Dtsch Med Wochenschr; 1986 Mar; 111(13):516-7. PubMed ID: 3456890 [No Abstract] [Full Text] [Related]
16. [Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients]. Bardin JM; Maisonneuve P; Nguyen M; Pinon F; Sultan Y Presse Med; 1986 Oct; 15(33):1686-7. PubMed ID: 2947123 [No Abstract] [Full Text] [Related]